We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Oral Fluid HIV Tests Give False-Positive Results

By Labmedica staff writers
Posted on 01 Jul 2008
There have been increases in the number of false-positive results for human immunodeficiency virus (HIV) in oral fluid testing in New York (NY, USA).

The Morbidity and Mortality Weekly Report (MMWR) of June 18, 2008, reviewed the increases in these false-positives, which were identified in New York City from the years 2005 to 2008, and the manner with which the officials there responded. More...
According to the report, the reason for the episodic increase in false-positive oral-fluid tests has not yet been determined. Currently, the New York City Department of Health and Mental Hygiene (NY, USA) suspended the use of oral fluid testing in its sexually transmitted infection (STI) clinics, and finger-stick whole-blood testing is the only rapid HIV test being used.

The "findings underscore the importance of confirming all reactive HIV tests, both from oral fluid and whole-blood specimens,” according to MMWR. They further indicate that the health department's "strategy of following-up reactive oral fluid test results with an immediate finger-stick whole-blood test reduced the number of apparent false-positive oral fluid test results and might be a useful strategy in other settings and locations.” The report also noted that, "The U.S. Center of Disease Control and Prevention [CDC; Atlanta, GA, USA] continues to encourage the use of rapid HIV tests because they increase the number of persons who are tested and who receive their test results.”

This report was provided by the Kaiser Daily Health Policy Report
(Menlo Park, CA, USA), a non-profit, private operating foundation focusing on major healthcare issues.


Related Links:
New York City Department of Health and Mental Hygiene
U.S. Center of Disease Control and Prevention
Kaiser Daily Health Policy Report

New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Hematology Consumables
Bioblood Devices
New
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Accurate immunotherapy selection for esophageal and GEJ carcinomas depends on consistent PD-L1 assessment (credit: Adobe Stock)

FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas

Esophageal and gastroesophageal junction carcinomas (GEJ) have a poor prognosis, with approximately 16,250 deaths in the United States in 2025 and a five-year relative survival of 21.9%.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.